Programmed Death of T Cells in HIV-1 Infection

  • Linde Meyaard
    Department of Clinical Viro-lmmunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, and Laboratory for Experimental and Clinical Immunology of the University of Amsterdam, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands.
  • Sigrid A. Otto
    Department of Clinical Viro-lmmunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, and Laboratory for Experimental and Clinical Immunology of the University of Amsterdam, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands.
  • Richard R. Jonker
    Department of Molecular Pathology, TNO Institute of Applied Radiobiology and Immunology, Rijswijk, The Netherlands.
  • M. Janneke Mijnster
    Netherlands Institute for Brain Research, Amsterdam, The Netherlands.
  • René P. M. Keet
    Department of Infectious Diseases, Municipal Health Service, Amsterdam, The Netherlands.
  • Frank Miedema
    Department of Clinical Viro-lmmunology, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, and Laboratory for Experimental and Clinical Immunology of the University of Amsterdam, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands.

抄録

<jats:p> In human immunodeficiency virus (HIV) infection, functional defects and deletion of antigen-reactive T cells are more frequent than can be explained by direct viral infection. On culturing, both CD4 <jats:sup>+</jats:sup> and CD8 <jats:sup>+</jats:sup> T cells from asymptomatic HIV-infected individuals died as a result of programmed cell death (apoptosis). Apoptosis was enhanced by activation with CD3 antibodies. Programmed cell death, associated with impaired T cell reactivity, may thus be responsible for the deletion of reactive T cells that contributes to HIV-induced immunodeficiency. </jats:p>

収録刊行物

  • Science

    Science 257 (5067), 217-219, 1992-07-10

    American Association for the Advancement of Science (AAAS)

被引用文献 (24)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ